BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11015636)

  • 1. Severe and moderate hypertriglyceridemia secondary to citalopram and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2000; 41(5):448-9. PubMed ID: 11015636
    [No Abstract]   [Full Text] [Related]  

  • 2. Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
    Pallanti S; Koran LM
    Am J Psychiatry; 1999 May; 156(5):796. PubMed ID: 10327919
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramaximal Dose of Ecitalopram-Associated Hematuria in an Adolescent With Obsessive-Compulsive Disorder: A Case Report.
    Naguy A; Abdelhamid HS; Elsori D; Alamiri B
    J Clin Psychopharmacol; 2020; 40(1):102-103. PubMed ID: 31834092
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 6. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-Dependent Escitalopram-Associated Ventricular Bigeminy.
    Naguy A; Al-Humoud AM; AlAwadhi DS; Khraibut B
    Am J Ther; 2020; 27(3):e307-e309. PubMed ID: 31567151
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
    Sarkar R; Klein J; Krüger S
    Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice.
    Kubera M; Simbirtsev A; Mathison R; Maes M
    Psychiatry Res; 2000 Nov; 96(3):255-66. PubMed ID: 11084221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small numbers, big impact.
    Smoller JW; Nierenberg AA
    Harv Rev Psychiatry; 1999; 7(2):109-13. PubMed ID: 10471249
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
    Wickham R; Varma A
    CNS Spectr; 2007 Aug; 12(8):578-9. PubMed ID: 17924512
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
    Joliat MJ; Brown EB; Miner CM
    J Clin Psychopharmacol; 2004 Aug; 24(4):464-7. PubMed ID: 15232349
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.
    Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG
    Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder.
    Storch EA; Larson MJ; Shapira NA; Ward HE; Murphy TK; Geffken GR; Valerio H; Goodman WK
    Depress Anxiety; 2006; 23(7):429-33. PubMed ID: 16841343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
    Sidi H; Asmidar D; Hod R; Jaafar NR; Guan NC
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):41-7. PubMed ID: 22122658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible combination of clozapine and specific serotonin reuptake inhibitors?].
    Caroli F; Aymard N; Viala A; Smagghe PO
    Encephale; 1995; 21(6):482-3. PubMed ID: 8674476
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
    Madeo B; Bettica P; Milleri S; Balestrieri A; Granata AR; Carani C; Rochira V
    J Sex Med; 2008 Oct; 5(10):2431-41. PubMed ID: 18410297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.